{"paper_id":"b6c9ee02-4c48-4787-ab51-5b9ec29d7a17","body_text":"Abstract\nOvarian endometrioma (OMA) and deep infiltrating endometriosis (DIE) have long been recognized to have different histology and, as such, postulated to be 2 separate disease entities. Few studies, however, have attempted to elucidate the causes for their differences. Making use of ectopic endometrial tissue samples from 25 and 20 women with OMA and DIE, respectively, and control endometrial tissue samples from 25 women without endometriosis, we conducted an immunohistochemical analysis to evaluate the expression of a group of carefully chosen markers for epithelial-mesenchymal transition (EMT), fibroblast-to-myofibroblast transdifferentiation (FMT), smooth muscle metaplasia (SMM), fibrosis, vascularity, hormonal receptors, and proteins involved in epigenetic modifications. We found that both OMA and DIE lesions exhibited the same cellular changes consistent with EMT, FMT, SMM, and fibrosis as already shown in animal models. Compared to OMA, DIE lesions underwent more thorough and extensive EMT, FMT, and SMM and, consequently, displayed significantly higher fibrotic content but less vascularity. The 2 conditions also showed different expression levels of hormonal receptors. Both OMA and DIE lesions, especially the latter, showed significantly higher staining of enhancer of zeste homolog 2, H3K9me3, and H3K27me3 than that of control endome-trium, suggesting progressive epigenetic changes concomitant with cellular ones. Finally, proteins that are known to be involved in fibrogenesis, such as thymocyte differentiation antigen 1 and peroxisome proliferator-activated receptor g, were also aberrantly expressed under both conditions. The many similarities shared by both OMA and DIE indicate that the 2 conditions may actually share the same pathogenesis/pathophysiology. Their differences, however, suggest that the source of these differences may result from the different lesional microenvironments.\nSimilar content being viewed by others\nReferences\nGiudice LC, Kao LC. Endometriosis. Lancet. 2004;364(9447):1789–1799.\nVon Rokitansky C. Ueber uterusdrusen-neubildung in uterus and ovarilsarcomen. Z Gesellschaft Aerzte Wein. 1860;186:445–473.\nRedwine DB. Age-related evolution in color appearance of endo-metriosis. Fertil Steril. 1987;48(6):1062–1063.\nNisolle M, Casanas-Roux F, Anaf V, Mine JM, Donnez J. Mor-phometric study of the stromal vascularization in peritoneal endo-metriosis. Fertil Steril. 1993;59(3):681–684.\nBrosens IA. Is mild endometriosis a progressive disease? Hum Reprod. 1994;9(12):2209–2211.\nHarirchian P, Gashaw I, Lipskind ST, et al. Lesion kinetics in a non-human primate model of endometriosis. Hum Reprod. 2012;27(8):2341–2351.\nJenkins S, Olive DL, Haney AF. Endometriosis: pathogenetic implications of the anatomic distribution. Obstet Gynecol. 1986;67(3):335–338.\nGylfason JT, Kristjansson KA, Sverrisdottir G, Jonsdottir K, Rafnsson V, Geirsson RT. Pelvic endometriosis diagnosed in an entire nation over 20 years. Am J Epidemiol. 2010;172(3):237–243.\nKoninckx PR, Martin DC. Deep endometriosis: a consequence of infiltration or retraction or possibly adenomyosis externa?. Fertil Steril. 1992;58(5):924–928.\nKoninckx PR, Ussia A, Adamyan L, Wattiez A, Donnez J. Deep endometriosis: definition, diagnosis, and treatment. Fertil Steril. 2012;98(3):564–571.\nAnaf V, Simon P, Fayt I, Noel J. Smooth muscles are frequent components of endometriotic lesions. Hum Reprod. 2000;15(4):767–771.\nKoninckx PR. Biases in the endometriosis literature. Illustrated by 20 years of endometriosis research in Leuven. Eur J Obstet Gynecol Reprod Biol. 1998;81(2):259–271.\nTosti C, Pinzauti S, Santulli P, Chapron C, Petraglia F. Pathoge-netic mechanisms of deep infiltrating endometriosis. Reprod Sci. 2015;22(9):1053–1059\nNisolle M, Donnez J. Peritoneal endometriosis, ovarian endome-triosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril. 1997;68(4):585–596.\nWu Y, Kajdacsy-Balla A, Strawn E, et al. Transcriptional characterizations of differences between eutopic and ectopic endometrium. Endocrinology. 2006;147(1):232–246.\nGarry R. Is insulin resistance an essential component of PCOS?: the endometriosis syndromes: a clinical classification in the presence of aetiological confusion and therapeutic anarchy. Hum Reprod. 2004;19(4):760–768.\nBrosens IA. Endometriosis—a disease because it is characterized by bleeding. Am J Obstet Gynecol. 1997;176(2):263–267.\nGuo SW, Ding D, Shen M, Liu X. Dating endometriotic ovarian cysts based on the content of cyst fluid and its potential clinical implications. Reprod Sci. 2015;22(7):873–883.\nZhang Q, Duan J, Olson M, Fazleabas A, Guo SW. Cellular changes consistent with epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the progression of experimental endometriosis in baboons. Reprod Sci. 2016;23(10):1409–1421.\nZhang Q, Duan J, Liu X, Guo SW. Platelets drive smooth muscle metaplasia and fibrogenesis in endometriosis through epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation. Mol Cell Endocrinol. 2016;428:1–16.\nItoga T, Matsumoto T, Takeuchi H, et al. Fibrosis and smooth muscle metaplasia in rectovaginal endometriosis. Pathol Int. 2003;53(6):371–375.\nKhare VK, Martin DC, Eltorky M. A comparative study of ovarian and pelvic wall-infiltrating endometriosis. J Am Assoc Gyne-col Laparosc. 1996;3(2):235–239.\nMatsuzaki S, Darcha C. Involvement of the Wnt/beta-catenin signaling pathway in the cellular and molecular mechanisms of fibrosis in endometriosis. PLoS One. 2013;8(10):e76808.\nMechsner S, Bartley J, Loddenkemper C, Salomon DS, Starzinski-Powitz A, Ebert AD. Oxytocin receptor expression in smooth muscle cells of peritoneal endometriotic lesions and ovarian endo-metriotic cysts. Fertil Steril. 2005;83(suppl 1):1220–1231.\nLiu X, Shen S, Qi Q, Zhang H, Guo SW. Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis. Hum Reprod. 2016;31(4):734–749.\nShen M, Liu X, Zhang H, Guo SW. Transforming growth factor β1 signaling coincides with mediated epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in drive the development of adenomyosis in mice. Hum Reprod. 2016. In press.\nZhang Q, Liu X, Guo SW. Progressive development of endome-triosis and its hindrance by anti-platelet treatment in mice with induced endometriosis. Reprod Biomed Online. 2017;34(2):124–136.\nKamergorodsky G, Ribeiro PA, Galvao MA, et al. Histologic classification of specimens from women affected by superficial endometriosis, deeply infiltrating endometriosis, and ovarian endometriomas. Fertil Steril. 2009;92(6):2074–2077.\nSchweppe KW, Dmowski WP, Wynn RM. Ultrastructural changes in endometriotic tissue during danazol treatment. Fertil Steril. 1981;36(1):20–26.\nSchweppe KW, Wynn RM. Endocrine dependency of endome-triosis: an ultrastructural study. Eur J Obstet Gynecol Reprod Biol. 1984;17(2-3):193–208.\nAbrao MS, Neme RM, Carvalho FM, Aldrighi JM, Pinotti JA. Histological classification of endometriosis as a predictor of response to treatment. Int J Gynaecol Obstet. 2003;82(1):31–40.\nZhang Q, Dong P, Liu X, Sakuragi N, Guo SW. Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis. Sci Rep, in press.\nBulun SE, Monsavais D, Pavone ME, et al. Role of estrogen receptor-beta in endometriosis. Semin Reprod Med. 2012;30(1):39–45.\nNoyes RW, Haman JO. Accuracy of endometrial dating; correlation of endometrial dating with basal body temperature and menses. Fertil Steril. 1953;4(6):504–517.\nHagood JS, Prabhakaran P, Kumbla P, et al. Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis. Am J Pathol. 2005;167(2):365–379.\nMann J, Chu DC, Maxwell A, et al. MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology. 2010;138(2):705–714, 14 e1-e4.\nLong Q, Liu X, Qi Q, Guo SW. Chronic stress accelerates the development of endometriosis in mouse through adrenergic receptor beta2. Hum Reprod. 2016;31(11):2506–2519.\nDing D, Liu X, Duan J, Guo SW. Platelets are an unindicted culprit in the development of endometriosis: clinical and experimental evidence. Hum Reprod. 2015;30(4):812–832.\nKoumas L, King AE, Critchley HO, Kelly RW, Phipps RP. Fibroblast heterogeneity: existence of functionally distinct Thy 1(+) and Thy 1(—) human female reproductive tract fibroblasts. Am J Pathol. 2001;159(3):925–935.\nPeeters LL, Vigne JL, Tee MK, Zhao D, Waite LL, Taylor RN. PPAR gamma represses VEGF expression in human endometrial cells: implications for uterine angiogenesis. Angiogenesis. 2005;8(4):373–379.\nHasegawa T, Hasegawa F, Hirose T, Sano T, Matsuno Y. Expression of smooth muscle markers in so called malignant fibrous histiocytomas. J Clin Pathol. 2003;(56):666–671.\nHinz B, Celetta G, Tomasek JJ, Gabbiani G, Chaponnier C. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell. 2001;12(9):2730–2741.\nRege TA, Hagood JS. Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis. FASEB J. 2006;20(8):1045–1054.\nBulun SE, Cheng YH, Pavone ME. Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis. Semin Reprod Med. 2010;28(1):36–43.\nHornung D, Waite LL, Ricke EA, Bentzien F, Wallwiener D, Taylor RN. Nuclear peroxisome proliferator-activated receptors alpha and gamma have opposing effects on monocyte chemotaxis in endometriosis. J Clin Endocrinol Metab. 2001;86(7):3108–3114.\nMcKinnon B, Bersinger NA, Huber AW, Kuhn A, Mueller MD. PPAR-gamma expression in peritoneal endometriotic lesions correlates with pain experienced by patients. Fertil Steril. 2010;93(1):293–296.\nXue Q, Lin Z, Cheng YH, et al. Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol Reprod. 2007;77(4):681–687.\nZhang Q, Ding D, Liu X, Guo SW. Activated platelets induce estrogen receptor beta expression in endometriotic stromal cells. Gynecol Obstet Invest. 2015;80(3):187–192.\nSignorile PG, Campioni M, Vincenzi B, D’Avino A, Baldi A. Rectovaginal septum endometriosis: an immunohistochemical analysis of 62 cases. In Vivo. 2009;23(3):459–464.\nMeyer JL, Zimbardi D, Podgaec S, Amorim RL, Abrao MS, Rainho CA. DNA methylation patterns of steroid receptor genes ESR1, ESR2, and PGR in deep endometriosis compromising the rectum. Int J Mol Med. 2014;33(4):897–904.\nVinci G, Arkwright S, Audebourg A, et al. Correlation between the clinical parameters and tissue phenotype in patients affected by deep-infiltrating endometriosis. Reprod Sci. 2016;23(9):1258–1268.\nNoel JC, Chapron C, Bucella D, et al. Estrogen and progesterone receptors in smooth muscle component of deep infiltrating endometriosis. Fertil Steril 2010;93(6):1774–1777.\nBarcena de Arellano ML, Gericke J, Reichelt U, et al. Immunohistochemical characterization of endometriosis-associated smooth muscle cells in human peritoneal endometriotic lesions. Hum Reprod. 2011;26(10):2721–2730.\nBoyle DP, McCluggage WG. Peritoneal stromal endometriosis: a detailed morphological analysis of a large series of cases of a common and under-recognised form of endometriosis. J Clin Pathol. 2009;62(6):530–533.\nClement PB. The pathology of endometriosis: a survey of the many faces of a common disease emphasizing diagnostic pitfalls and unusual and newly appreciated aspects. Adv Anat Pathol. 2007;14(4):241–260.\nMai KT, Yazdi HM, Perkins DG, Parks W. Pathogenetic role of the stromal cells in endometriosis and adenomyosis. Histo-pathology. 1997;30(5):430–442.\nDoss BJ, Wanek SM, Jacques SM, Qureshi F, Ramirez NC, Lawrence WD. Ovarian smooth muscle metaplasia: an uncommon and possibly underrecognized entity. Int J Gynecol Pathol. 1999;18(1):58–62.\nFukunaga M. Smooth muscle metaplasia in ovarian endometrio-sis. Histopathology. 2000;36(4):348–352.\nBonte H, Chapron C, Vieira M, et al. Histologic appearance of endometriosis infiltrating uterosacral ligaments in women with painful symptoms. J Am Assoc Gynecol Laparosc. 2002;9(4):519–524.\nvan Kaam KJ, Schouten JP, Nap AW, Dunselman GA, Groothuis PG. Fibromuscular differentiation in deeply infiltrating endome-triosis is a reaction of resident fibroblasts to the presence of ecto-pic endometrium. Hum Reprod. 2008;23(12):2692–2700.\nLeyendecker G, Herbertz M, Kunz G, Mall G. Endometriosis results from the dislocation of basal endometrium. Hum Reprod. 2002;17(10):2725–2736.\nCornillie FJ, Oosterlynck D, Lauweryns JM, Koninckx PR. Deeply infiltrating pelvic endometriosis: histology and clinical significance. Fertil Steril. 1990;53(6):978–983.\nStovall DW, Anners JA, Halme J. Immunohistochemical detection of type I, III, and IV collagen in endometriosis implants. Fertil Steril. 1992;57(5):984–989.\nMatsuzaki S, Canis M, Darcha C, Dechelotte P, Pouly JL, Bruhat MA. Fibrogenesis in peritoneal endometriosis. A semiquantitative analysis of type-I collagen. Gynecol Obstet Invest. 1999;47(3):197–199.\nQiu JJ, Liu MH, Zhang ZX, Chen LP, Yang QC, Liu HB. Transvaginal color Doppler sonography predicts ovarian interstitial fibrosis and microvascular injury in women with ovarian endo-metriotic cysts. Acta Obstet Gynecol Scand. 2012;91(5):605–612.\nFernandez-Shaw S, Shorter SC, Naish CE, Barlow DH, Starkey PM. Isolation and purification of human endometrial stromal and glandular cells using immunomagnetic microspheres. Hum Reprod. 1992;7(2):156–161.\nZhou Y, Hagood JS, Murphy-Ullrich JE. Thy-1 expression regulates the ability of rat lung fibroblasts to activate transforming growth factor-beta in response to fibrogenic stimuli. Am J Pathol. 2004;165(2):659–669.\nVarisco BM, Ambalavanan N, Whitsett JA, Hagood JS. Thy-1 signals through PPARgamma to promote lipofibroblast differentiation in the developing lung. Am J Respir Cell Mol Biol. 2012;46(6):765–772.\nSanders YY, Kumbla P, Hagood JS. Enhanced myofibroblastic differentiation and survival in Thy-1(—) lung fibroblasts. Am J Respir Cell Mol Biol. 2007;36(2):226–235.\nSanders YY, Tollefsbol TO, Varisco BM, Hagood JS. Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts. Am J Respir Cell Mol Biol. 2011;45(1):16–23.\nNeveu WA, Mills ST, Staitieh BS, Sueblinvong V. TGF-beta1 epigenetically modifies Thy-1 expression in primary lung fibroblasts. Am J Physiol Cell Physiol. 2015;309(9):C616-C626.\nOverton CE, Fernandez-Shaw S, Hicks B, Barlow DH, Starkey P. In vitro culture of endometrial stromal and gland cells as a model for endometriosis: the effect of peritoneal fluid on proliferation. Fertil Steril. 1997;67(1):51–56.\nLi T, He H, Liu R, Wang SX, Pu DM. Isolation and identification of epithelial and stromal stem cells from eutopic endometrium of women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2014;178:89–94.\nHornung D, Klingel K, Dohrn K, Kandolf R, Wallwiener D, Taylor RN. Regulated on activation, normal T-cell-expressed and -secreted mRNA expression in normal endometrium and endome-triotic implants: assessment of autocrine/paracrine regulation by in situ hybridization. Am J Pathol. 2001;158(6):1949–1954.\nLebovic DI, Kavoussi SK, Lee J, Banu SK, Arosh JA. PPAR-gamma activation inhibits growth and survival of human endo-metriotic cells by suppressing estrogen biosynthesis and PGE2 signaling. Endocrinology. 2013;154(12):4803–4813.\nKon K, Ikejima K, Hirose M, et al. Pioglitazone prevents early-phase hepatic fibrogenesis caused by carbon tetrachloride. Biochem Biophys Res Commun. 2002;291(1):55–61.\nDantas AT, Pereira MC, de Melo Rego MJ, et al. The role of PPAR Gamma in systemic sclerosis. PPAR Res. 2015;2015:124624.\nHinz B, Phan SH, Thannickal VJ, et al. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol. 2012;180(4):1340–1355.\nGuo SW. Epigenetics of endometriosis. Mol Hum Reprod. 2009;15(10):587–607.\nLi X, Liu X, Guo SW. Histone deacetylase inhibitors as therapeutics for endometriosis. Exp Rev Obstet Gynecol. 2014;7:451–466.\nYan D, Liu X, Guo SW. Endometriosis-derived thromboxane A2 induces neurite outgrowth. Reprod Sci. 2017;24(6):829–835.\nGuo SW, Yan D, Liu X. Sensory nerve-derived substance P (SP) and calcitonin gene-related peptide (CGRP) promote fibrogenesis in endometriosis. In: The 13th World Congress on Endometriosis. Vancouver, British Columbia; 2017.\nDonnez O, Soares M, Defrere S, et al. Nerve fiber density in deep nodular endometriotic lesions induced in a baboon experimental model. Fertil Steril. 2013;100(4):1144–1150.\nAnaf V, El Nakadi I, De Moor V, Chapron C, Pistofidis G, Noel JC. Increased nerve density in deep infiltrating endometriotic nodules. Gynecol Obstet Invest 2011;71(2):112–117.\nBrosens I, Gordts S, Benagiano G. Endometriosis in adolescents is a hidden, progressive and severe disease that deserves attention, not just compassion. Hum Reprod. 2013;28(8):2026–2031.\nRedwine DB. Ovarian endometriosis: a marker for more extensive pelvic and intestinal disease. Fertil Steril. 1999;72(2):310–315.\nAuthor information\nAuthors and Affiliations\nCorresponding author\nRights and permissions\nAbout this article\nCite this article\nLiu, X., Zhang, Q. & Guo, SW. Histological and Immunohistochemical Characterization of the Similarity and Difference Between Ovarian Endometriomas and Deep Infiltrating Endometriosis. Reprod. Sci. 25, 329–340 (2018). https://doi.org/10.1177/1933719117718275\nPublished:\nVersion of record:\nIssue date:\nDOI: https://doi.org/10.1177/1933719117718275","source_license":"CC0","license_restricted":false}